1 June 2016 - Myeloma UK has awarded a health services research grant to NICE, to fund an exploratory study on how patient preferences could be captured and included in health technology assessment.

The £120,000 grant will fund a two year methodological study at NICE. It will explore best practice in the use of different methods and technologies for capturing information about patient preferences relating to their condition and the treatments they receive for it. The study will be undertaken in consultation with patient groups, experts and other leading HTA bodies across the world.

The Health Services Research programme at Myeloma UK focuses on obtaining high quality evidence to help improve patient outcomes, wellbeing and quality of life, and looks to shape improvements in the way healthcare is funded and delivered. Following a competitive open grant round, the NICE study was one of two research proposals to be awarded funding.

For more details, go to: http://www.pharmatimes.com/news/nice_to_research_patient_preferences_in_hta_1033029